JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.61% |
| 2 | Technology | 23.17% |
| 3 | Financials | 10.12% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Healthcare | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4701
CEMIG Preferred Shares
CIG
$6.15B
| $661K | ﹤0.01% |
373,590
-74,932
| -17% | -$145K |
2013 Q2
46 quarters
|
|
4702
Holley
HLLY
$284M
| $660K | ﹤0.01% |
218,645
+74,885
| +52% | +$210K |
2021 Q4
12 quarters
|
|
4703
Mesa Laboratories
MLAB
$742M
| $660K | ﹤0.01% |
5,003
-3,403
| -40% | -$418K |
2017 Q4
28 quarters
|
|
4704
CALL
Riot Platforms
RIOT
$7.4B
| $658K | ﹤0.01% |
64,400
-66,400
| -51% | -$723K |
2024 Q3
1 quarter
|
|
4705
Jack in the Box
JACK
$239M
| $656K | ﹤0.01% |
15,757
-379
| -2% | -$17.5K |
2013 Q2
46 quarters
|
|
4706
Silvercrest Asset Management
SAMG
$82.4M
| $654K | ﹤0.01% |
35,583
+14,978
| +73% | +$266K |
2017 Q4
28 quarters
|
|
|
GATO
4707
DELISTED
Gatos Silver, Inc.
GATO
| $654K | ﹤0.01% |
46,794
-26,424
| -36% | -$430K |
2023 Q1
7 quarters
|
|
4708
Vitamin Cottage Natural Grocers
NGVC
$705M
| $653K | ﹤0.01% |
16,447
-32,963
| -67% | -$1.14M |
2017 Q3
29 quarters
|
|
4709
Ranger Energy Services
RNGR
$366M
| $653K | ﹤0.01% |
42,153
+35,157
| +503% | +$504K |
2023 Q1
7 quarters
|
|
4710
Nomura Holdings
NMR
$28.4B
| $652K | ﹤0.01% |
112,675
+19,938
| +21% | +$113K |
2018 Q3
25 quarters
|
|
|
HDUS
4711
Hartford Disciplined US Equity ETF
HDUS
$106M
| $647K | ﹤0.01% |
11,450
-691
| -6% | -$39.5K |
2023 Q3
5 quarters
|
|
4712
PUT
Bloom Energy
BE
$85.2B
| $646K | ﹤0.01% |
+29,100
| New | +$510K |
2024 Q4
0 quarters
|
|
|
ATYR
4713
aTyr Pharma
ATYR
$28.2M
| $646K | ﹤0.01% |
178,532
+147,092
| +468% | +$445K |
2022 Q4
8 quarters
|
|
4714
Arcus Biosciences
RCUS
$3.11B
| $645K | ﹤0.01% |
43,351
-334
| -0.8% | -$5.46K |
2018 Q1
27 quarters
|
|
4715
Alpha Architect 1-3 Month Box ETF
BOXX
$14.6B
| $643K | ﹤0.01% |
+5,831
| New | +$639K |
2024 Q4
0 quarters
|
|
4716
Pure Cycle
PCYO
$263M
| $641K | ﹤0.01% |
50,591
+36,232
| +252% | +$442K |
2017 Q4
28 quarters
|
|
4717
Bioceres Crop Solutions
BIOX
$21.8M
| $640K | ﹤0.01% |
105,301
+15,328
| +17% | +$105K |
2020 Q4
16 quarters
|
|
4718
iShares US Basic Materials ETF
IYM
$1.13B
| $634K | ﹤0.01% |
4,883
+1,918
| +65% | +$277K |
2020 Q4
16 quarters
|
|
4719
iShares Morningstar Small-Cap ETF
ISCB
$274M
| $634K | ﹤0.01% |
10,800
+125
| +1% | +$7.56K |
2020 Q4
16 quarters
|
|
4720
MaxCyte
MXCT
$110M
| $632K | ﹤0.01% |
151,950
-42,049
| -22% | -$159K |
2021 Q3
13 quarters
|
|
4721
CALL
Illumina
ILMN
$41.2B
| $628K | ﹤0.01% |
4,700
+4,100
| +683% | +$584K |
2024 Q3
1 quarter
|
|
4722
United States Brent Oil Fund
BNO
$782M
| $626K | ﹤0.01% |
20,908
| – | – |
2018 Q4
24 quarters
|
|
4723
NextNav
NN
$2.36B
| $626K | ﹤0.01% |
40,225
+7,637
| +23% | +$102K |
2022 Q2
10 quarters
|
|
4724
loanDepot
LDI
$215M
| $625K | ﹤0.01% |
306,221
+126,615
| +70% | +$282K |
2024 Q1
3 quarters
|
|
4725
Bank7 Corp
BSVN
$528M
| $624K | ﹤0.01% |
13,370
+11,644
| +675% | +$514K |
2018 Q4
24 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 509 new, 3,351 increased, 2,465 reduced and 522 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 509 new positions and closed 522 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.